HFA
TEVA icon

Hoover Financial Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Hoover Financial Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$1K Hold
75
– – ﹤0.01% 626
2021
Q1 		$1K Buy
+75
New +$860 ﹤0.01% 579
2020
Q3 		– Sell
-275
Closed -$3K – 438
2020
Q2 		$3K Buy
+275
New +$3.11K ﹤0.01% 433

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Hoover Financial Advisors's TEVA Position: Q2 2021 in Review

Hoover Financial Advisors held its Teva Pharmaceuticals (TEVA) position steady in Q2 2021 at 75 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #626.

Hoover Financial Advisors first reported a position in TEVA in Q2 2020 and has held it in 3 quarters since. The position peaked at $3K in Q2 2020. 440 funds tracked by Wall St. Rank hold TEVA as of Q2 2021.

  • Hoover Financial Advisors held 75 shares of Teva Pharmaceuticals worth $1K as of Q2 2021.
  • Hoover Financial Advisors left its Teva Pharmaceuticals share count unchanged in Q2 2021.
  • Teva Pharmaceuticals made up ﹤0.01% of Hoover Financial Advisors's portfolio in Q2 2021, its #626 holding.
  • Hoover Financial Advisors first reported a position in Teva Pharmaceuticals in Q2 2020 and has held it in 3 quarters since.
  • Hoover Financial Advisors's Teva Pharmaceuticals position peaked at $3K in Q2 2020.
  • 440 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2021.

Based on Hoover Financial Advisors's 13F filing for Q2 2021, filed 28 Jul 2021.